Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page
- Check6 days agoChange DetectedThe change is a minor revision label update on the page (from v3.3.1 to v3.3.2) with no impact on the study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision: v3.3.1 is now displayed, replacing v3.2.0. This is a minor administrative update and does not alter study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved a site-wide government funding status notice about NIH operations and potential processing delays. No study-related content was added or changed.SummaryDifference0.4%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedNo significant changes observed between the two screenshots; the page content and layout appear unchanged.SummaryDifference0.5%

- Check63 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference3%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.